117 related articles for article (PubMed ID: 26829850)
1. [COLD-ADAPTED A/KRASNODAR/101/35/59 (H2N2) STRAIN--A PROMISING STRAIN-DONOR OF ATTENUATION FOR PROCURATION OF LIVE INFLUENZA VACCINES].
Markushin SG; Tsfasman TM; Terekhov AV; Lisovskaya KV; Akopova II
Zh Mikrobiol Epidemiol Immunobiol; 2015; (5):27-32. PubMed ID: 26829850
[TBL] [Abstract][Full Text] [Related]
2. [COMPARATIVE STUDY OF IMMUNOGENICITY AND PROTECTIVE EFFECT OF LIVE COLD-ADAPTED AND INACTIVATED VACCINES AGAINST TYPE A INFLUENZA].
Kashirina OS; Chernikova MI; Vasiliev YM
Zh Mikrobiol Epidemiol Immunobiol; 2015; (3):38-46. PubMed ID: 26259268
[TBL] [Abstract][Full Text] [Related]
3. [Increase of immunogenicity of cold-adapted influenza vaccine by using adjuvant].
Markushin SG; Gendon IuZ; Krivtsov GG; Akopova II; Sukhno AS; Pereverzev AD
Zh Mikrobiol Epidemiol Immunobiol; 2010; (5):29-34. PubMed ID: 21061574
[TBL] [Abstract][Full Text] [Related]
4. [New cold-adapted donor strains for live influenza vaccine].
Gendon IuZ; Markushin SG; Tsfasman TM; Akopova II; Akhmatova NK; Koptiaeva IB
Vopr Virusol; 2013; 58(1):11-7. PubMed ID: 23785755
[TBL] [Abstract][Full Text] [Related]
5. Characterization of live influenza vaccine donor strain derived from cold-adaptation of X-31 virus.
Lee KH; Seo SU; Song JM; Lee CM; Kim HA; Seong BL
Vaccine; 2006 Mar; 24(11):1966-74. PubMed ID: 16343703
[TBL] [Abstract][Full Text] [Related]
6. [Cold-adapted strain of A/Leningrad/134/47/57 (H2N2)--a special attenuation donor of live influenza vaccine for children and the isolation of its recombinants].
Garmashova LM; Polezhaev FI; Aleksandrova GI
Vopr Virusol; 1984; 29(1):28-31. PubMed ID: 6710978
[TBL] [Abstract][Full Text] [Related]
7. [MECHANISMS OF ATTENUATION OF COLD-ADAPTED STRAIN A/KRASNO- DAR/101/35/59 (H2N2)].
Markushin SG; Svitich OA; Kinkulkina AR; Koptyaeva IB; Lisovskaya KV
Zh Mikrobiol Epidemiol Immunobiol; 2016; (2):49-56. PubMed ID: 27228671
[TBL] [Abstract][Full Text] [Related]
8. Four viral genes independently contribute to attenuation of live influenza A/Ann Arbor/6/60 (H2N2) cold-adapted reassortant virus vaccines.
Snyder MH; Betts RF; DeBorde D; Tierney EL; Clements ML; Herrington D; Sears SD; Dolin R; Maassab HF; Murphy BR
J Virol; 1988 Feb; 62(2):488-95. PubMed ID: 3336068
[TBL] [Abstract][Full Text] [Related]
9. [Immunogenicity of attenuated reassortants of influenza A virus /Leningrad/134/47/57 (H2N2) for mice, depending on their genome].
Egorov AIu; Garmashova LM; Nevedomskaia GN; Bogomolova LI; Khaĭder AM; Aleksandrova GI
Vopr Virusol; 1994; 39(5):198-201. PubMed ID: 7716900
[TBL] [Abstract][Full Text] [Related]
10. A live attenuated cold-adapted influenza A H7N3 virus vaccine provides protection against homologous and heterologous H7 viruses in mice and ferrets.
Joseph T; McAuliffe J; Lu B; Vogel L; Swayne D; Jin H; Kemble G; Subbarao K
Virology; 2008 Aug; 378(1):123-32. PubMed ID: 18585748
[TBL] [Abstract][Full Text] [Related]
11. [Safety and high immunogenicity for children 3 to 15 of a mono- and a divaccine from recombinant influenza A/Brazil /11/78 (H1N1) and A/Bangkok/1/79 (H3N2) viruses obtained from a special donor attenuation base--the cold-adapted virus A/Leningrad/134/47/57 (H2N2)].
Polezhaev FI; Budilovskiĭ GN; Garmashova LM; Romeĭko-Gurko IuR; Egorov AIu
Vopr Virusol; 1983; 28(6):710-4. PubMed ID: 6670253
[TBL] [Abstract][Full Text] [Related]
12. [Role of individual genes in expression of phenotypic properties of the cold-adapted strain A/Leningrad/134/47/57 (H2N2)-a donor of attenuation of live influenza vaccine].
Medvedeva TE; Kudriavtseva VK; Nevedomskaia GN; Zhikhareva IV; Gushchina MI; Zolotarev FN; Vodeĭko GM; Lisovskaia KV; Iotov VV; Khaĭder MI
Genetika; 1993 Apr; 29(4):681-9. PubMed ID: 8354475
[TBL] [Abstract][Full Text] [Related]
13. [Restriction analysis of genome composition of live influenza vaccine].
Kiseleva IV; Larionova NV; Teley LC; Rudenko LG
Vopr Virusol; 2011; 56(3):28-32. PubMed ID: 21786624
[TBL] [Abstract][Full Text] [Related]
14. Master donor viruses A/Leningrad/134/17/57 (H2N2) and B/USSR/60/69 and derived reassortants used in live attenuated influenza vaccine (LAIV) do not display neurovirulent properties in a mouse model.
Voeten JT; Kiseleva IV; Glansbeek HL; Basten SM; Drieszen-van der Cruijsen SK; Rudenko LG; van den Bosch H; Heldens JG
Arch Virol; 2010 Sep; 155(9):1391-9. PubMed ID: 20532926
[TBL] [Abstract][Full Text] [Related]
15. The attenuation phenotype conferred by the M gene of the influenza A/Ann Arbor/6/60 cold-adapted virus (H2N2) on the A/Korea/82 (H3N2) reassortant virus results from a gene constellation effect.
Subbarao EK; Perkins M; Treanor JJ; Murphy BR
Virus Res; 1992 Sep; 25(1-2):37-50. PubMed ID: 1413993
[TBL] [Abstract][Full Text] [Related]
16. [Characterization of cold-adapted influenza strain A/HongKong/1/68/162/35 as a potential donor of attenuation and high reproduction].
Tsybalova LM; Gorev NE; Potapchuk MV; Repko IA; Korotkov AV; Sergeeva MV; Komissarov AB; Pisareva MM; Kuznetsov VV; Grudinin MP; Kiselev OI
Vopr Virusol; 2012; 57(6):13-7. PubMed ID: 23477248
[TBL] [Abstract][Full Text] [Related]
17. [Peculiarity of reassortment of current wild type influenza viruses with master donor viruses for live influenza vaccine].
Kiseleva IV; Bazhenova EA; Larionova NV; Fedorova EA; Dubrovina IA; Isakova-Sivak IN; Rudenko LG
Vopr Virusol; 2013; 58(5):26-31. PubMed ID: 24640168
[TBL] [Abstract][Full Text] [Related]
18. Protective efficacy of intranasal cold-adapted influenza A/New Caledonia/20/99 (H1N1) vaccines comprised of egg- or cell culture-derived reassortants.
Palker T; Kiseleva I; Johnston K; Su Q; Toner T; Szymkowiak C; Kwan WS; Rubin B; Petrukhin L; Wlochowski J; Monteiro J; Kraiouchkine N; DiStefano D; Rudenko L; Shaw A; Youil R
Virus Res; 2004 Oct; 105(2):183-94. PubMed ID: 15351492
[TBL] [Abstract][Full Text] [Related]
19. Further studies on cold adapted variants of human influenza virus A/Krasnodar/101/59 (H2N2) with special reference to genetic stability of attenuation markers.
Panzig B; Lisovskaya KB; Herrmann B; Klimov A; Döhner L
Acta Virol; 1991 Aug; 35(4):332-42. PubMed ID: 1686959
[TBL] [Abstract][Full Text] [Related]
20. An open-label phase I trial of a live attenuated H2N2 influenza virus vaccine in healthy adults.
Talaat KR; Karron RA; Liang PH; McMahon BA; Luke CJ; Thumar B; Chen GL; Min JY; Lamirande EW; Jin H; Coelingh KL; Kemble GW; Subbarao K
Influenza Other Respir Viruses; 2013 Jan; 7(1):66-73. PubMed ID: 22417012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
